Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer.
Saved in:
| Title: | Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. |
|---|---|
| Authors: | Kaynak A; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Vallabhapurapu SD; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Smith EP; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Davis HW; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Lewis CS; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Ahn J; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Muller P; Masaryk Memorial Cancer Institute, Research Centre for Applied Molecular Oncology, Zluty Kopec 7, 656 53 Brno, Czech Republic., Vojtesek B; Masaryk Memorial Cancer Institute, Research Centre for Applied Molecular Oncology, Zluty Kopec 7, 656 53 Brno, Czech Republic., Stringer KF; Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA., Franco RS; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Bogdanov VY; Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, USA; (formerly at Universityof Cincinnati)., Shao WH; Division of Rheumatology, Allergy & Immunology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Qi X; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA. |
| Source: | Cancers [Cancers (Basel)] 2025 Apr 04; Vol. 17 (7). Date of Electronic Publication: 2025 Apr 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40227806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kaynak+A%22">Kaynak A</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Vallabhapurapu+SD%22">Vallabhapurapu SD</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Smith+EP%22">Smith EP</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Davis+HW%22">Davis HW</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Lewis+CS%22">Lewis CS</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Ahn+J%22">Ahn J</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Muller+P%22">Muller P</searchLink>; Masaryk Memorial Cancer Institute, Research Centre for Applied Molecular Oncology, Zluty Kopec 7, 656 53 Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Vojtesek+B%22">Vojtesek B</searchLink>; Masaryk Memorial Cancer Institute, Research Centre for Applied Molecular Oncology, Zluty Kopec 7, 656 53 Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Stringer+KF%22">Stringer KF</searchLink>; Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.<br /><searchLink fieldCode="AU" term="%22Franco+RS%22">Franco RS</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Bogdanov+VY%22">Bogdanov VY</searchLink>; Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, USA; (formerly at Universityof Cincinnati).<br /><searchLink fieldCode="AU" term="%22Shao+WH%22">Shao WH</searchLink>; Division of Rheumatology, Allergy & Immunology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.<br /><searchLink fieldCode="AU" term="%22Qi+X%22">Qi X</searchLink>; Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2025 Apr 04; Vol. 17 (7). <i>Date of Electronic Publication: </i>2025 Apr 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40227806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers17071224 Languages: – Code: eng Text: English Titles: – TitleFull: Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kaynak A – PersonEntity: Name: NameFull: Vallabhapurapu SD – PersonEntity: Name: NameFull: Smith EP – PersonEntity: Name: NameFull: Davis HW – PersonEntity: Name: NameFull: Lewis CS – PersonEntity: Name: NameFull: Ahn J – PersonEntity: Name: NameFull: Muller P – PersonEntity: Name: NameFull: Vojtesek B – PersonEntity: Name: NameFull: Stringer KF – PersonEntity: Name: NameFull: Franco RS – PersonEntity: Name: NameFull: Bogdanov VY – PersonEntity: Name: NameFull: Shao WH – PersonEntity: Name: NameFull: Qi X IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 04 Text: 2025 Apr 04 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2072-6694 Numbering: – Type: volume Value: 17 – Type: issue Value: 7 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |